Showing results (1451-1460 of 1,792) with videos related to

Sort By:
Pageof 180
Hepatology Communications|July 12, 2022
Response to immunotherapy plus anti-angiogenic agent combination challenges hepatocellular carcinoma prognostic scoresXavier Adhoute, Thomas Wolf
Hepatology Communications|April 25, 2022
Alcohol-associated fibrosis in females is mediated by female-specific activation of lysine demethylases KDM5B and KDM5CMichael Schonfeld, Janice Averilla, Sumedha Gunewardena, et al.
Hepatology Communications|July 19, 2022
Molecular determinants of peri-apical targeting of inositol 1,4,5-trisphosphate receptor type 3 in cholangiocytesMichele A Rodrigues, Dawidson A Gomes, Romina Fiorotto, et al.
Hepatology Communications|July 20, 2022
Inhibition of CBP/β-catenin signaling ameliorated fibrosis in cholestatic liver diseaseMasamichi Kimura, Koji Nishikawa, Yosuke Osawa, et al.
Hepatology Communications|July 22, 2022
Bile acid conjugation deficiency causes hypercholanemia, hyperphagia, islet dysfunction, and gut dysbiosis in miceBandar D Alrehaili, Mikang Lee, Shogo Takahashi, et al.
Hepatology Communications|July 22, 2022
Rhesus rotavirus receptor-binding site affects high mobility group box 1 release, altering the pathogenesis of experimental biliary atresiaSujit K Mohanty, Bryan Donnelly, Haley Temple, et al.
Hepatology Communications|April 26, 2022
Impact of the new definition of metabolic dysfunction-associated fatty liver disease on detection of significant liver fibrosis in US adolescentsStefano Ciardullo, Marco Carbone, Pietro Invernizzi, et al.
Hepatology Communications|April 19, 2022
Interaction of metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019Martín Uriel Vázquez-Medina, Eira Cerda-Reyes, Alberto Galeana-Pavón, et al.
Hepatology Communications|October 9, 2019
Fine-Tuning TLR-7-Based Therapy for Functional HBV CureAntonio Bertoletti, Nina Le Bert
Hepatology Communications|October 9, 2019
Development of a Plasma Screening Panel for Pediatric Nonalcoholic Fatty Liver Disease Using MetabolomicsRichard D Khusial, Catherine E Cioffi, Shelley A Caltharp, et al.
Pageof 180